Yao Fenghua, Zhang Li, Yin Zhong, Fu Bo, Feng Zhe, He Zongze, Li Qinggang, Li Jijun, Chen Xiangmei
Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases Beijing, China.
First Hospital Affiliated to The Chinese PLA General Hospital Beijing, China.
Int J Clin Exp Pathol. 2017 Nov 1;10(11):10998-11005. eCollection 2017.
Interleukin-35 (IL-35) is a novel immunosuppressive and anti-inflammatory cytokine. IL-35 is mainly secreted by regulatory T cells (Tregs), and exerts its effects through inducing proliferation of Tregs and reducing activity of helper T cells Th17. However, the effect of IL-35 on sepsis-associated acute kidney injury (SA-AKI) remains unclear. This study is aimed to examine the expression and role of IL-35 in an animal model of SA-AKI induced by cecal ligation and puncture (CLP). Eleven C57 male mice with SA-AKI and eight controls were used, and blood and kidney tissues were collected. Blood creatinine (Cr), urea nitrogen (BUN), alanine transaminase (ALT) and aspartate transaminase (AST) were measured to assess kidney and liver injury. The renal morphology and cell apoptosis were examined. The mRNA and protein expression levels of IL-35 in kidney tissues were tested by qRT-PCR, IHC-P, IF, and ELISA. Biochemical and histological examinations indicated CLP induced SA-AKI in mice. TUNEL assay showed apoptosis of renal tubular epithelial cells in SA-AKI mice. The mRNA and protein expression of IL-12α and EBI3 in kidney tissues decreased significantly in SA-AKI mice compared with those in sham controls. IL-35 levels in kidney tissues displayed a significantly negative correlation with the levels of Cr ( = -0.584, = 0.009), ALT ( = -0.549, = 0.015), AST ( = -0.475, = 0.04), but not with BUN ( = -0.437, = 0.061). These results demonstrated that IL-35 is associated with the pathological process of SA-AKI, and might represent a potential therapeutic agent for SA-AKI treatment.
白细胞介素-35(IL-35)是一种新型的免疫抑制和抗炎细胞因子。IL-35主要由调节性T细胞(Tregs)分泌,并通过诱导Tregs增殖和降低辅助性T细胞Th17的活性发挥作用。然而,IL-35在脓毒症相关性急性肾损伤(SA-AKI)中的作用仍不清楚。本研究旨在检测IL-35在盲肠结扎穿孔(CLP)诱导的SA-AKI动物模型中的表达及作用。使用11只患有SA-AKI的C57雄性小鼠和8只对照小鼠,采集血液和肾脏组织。检测血肌酐(Cr)、尿素氮(BUN)、谷丙转氨酶(ALT)和谷草转氨酶(AST)以评估肾脏和肝脏损伤。检查肾脏形态和细胞凋亡情况。通过qRT-PCR、免疫组化-P(IHC-P)、免疫荧光(IF)和酶联免疫吸附测定(ELISA)检测肾脏组织中IL-35的mRNA和蛋白表达水平。生化和组织学检查表明CLP诱导了小鼠的SA-AKI。TUNEL检测显示SA-AKI小鼠肾小管上皮细胞凋亡。与假手术对照组相比,SA-AKI小鼠肾脏组织中IL-12α和EBI3的mRNA和蛋白表达显著降低。肾脏组织中IL-35水平与Cr水平(r = -0.584,P = 0.009)、ALT水平(r = -0.549,P = 0.015)、AST水平(r = -0.475,P = 0.04)呈显著负相关,但与BUN水平(r = -0.437,P = 0.061)无相关性。这些结果表明IL-35与SA-AKI的病理过程相关,可能是SA-AKI治疗的一种潜在治疗药物。